Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

Results found: 2

first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  parallel trade
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
EN
One of the basic principles of European Union – free movement of goods, makes the phenomena of parallel trade in the pharmaceutical market possible. Access to all medicines, including access to the most effective therapies is very important for public health. There are two important aspects strongly influencing access: drugs affordability and the presence of products in the market. The latter can be sometimes jeopardized by an excessive parallel export. Access to the newest pharma-ceutical technologies can positively influence quality of life of the society and thus, in the longer term, can trigger many positive consequences for particular markets and for the whole EU. The aim of this article is to present the economic effects of parallel trade in the pharmaceutical markets in EU. Economic factors influencing presence, form and scale of parallel trade are presented, as well as its’ macro and microeconomic consequences.
PL
Zagadnienie handlu równoległego produktami leczniczymi to szczególnie interesujące zagadnienie europejskiego prawa konkurencji. Jego rosnąca rola stanowi zarazem istotny problem dla producentów leków, którzy osiągają w związku z jego funkcjonowaniem znacznie niższe zyski. W związku z realizowaniem handlu równoległego w ramach Unii Europejskiej ogromnego znaczenia nabiera kontrola organów antymonopolowych oraz sądów, które sprawują pieczę nad należytym realizowaniem zasad prawa konkurencji. Niniejszy artykuł stanowi analizę porozumień ograniczających handel równoległy i próbę ich oceny pod kątem prawnym i społecznym. Autor omawia jedno z najistotniejszych orzeczeń Europejskiego Trybunału Sprawiedliwości, które dotyczyło przedmiotowego zagadnienia. Artykuł wieńczą wnioski oraz krytyczne spojrzenie na zagadnienie ograniczania handlu równoległego
EN
Parallel trade of pharmaceutical products is a particularly interesting aspect of European competition law. The increasing role of parallel trade is also of significance to the producers of pharmaceuticals, as it results in the lowering of their profits. Due to the existence of parallel trade within the EU, the supervisory role of antitrust authorities and courts over competition law compliance is of essence. This article analyses anti-competitive agreements concerning the limitation of parallel trade and attempts to assess their legal and social status. Described is also one of the most relevant judgments of the European Court of Justice concerning this issue. The article closes with final conclusions and a critical insight into the issue of parallel trade limitation.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.